Clinical Trial Update: Effects of Glucagon-Like Peptide-1 Analogs on Sexuality [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating the effects of GLP-1 analogs on sexuality in individuals with sexual functioning concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction
• Sexual Functioning Disorders

Drugs mentioned

• Glucagon-Like Peptide-1 Analogs (GLP-1 analog)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Sexual Functioning | Phase 2 | Status: COMPLETED